Theravance Respiratory Company, LLC (Tables)

6 Months Ended

Jun. 30, 2022

Theravance Respiratory Company, LLC

Summary financial information

	Three Months Ended June 30,				Six Months Ended June 30,
(In thousands)	2022		2021		2022		2021
Royalty revenue and gross profit	$	42,720	$	26,386	$	72,029	$	48,470
Income from continuing operations		42,581		26,050		71,693		44,853
Net income		33,091		25,796		62,632		44,116